Jushi Holdings (JUSHF) Other Non-Current Liabilities (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Other Non-Current Liabilities came in at $30.8 million in Q1 2026, up 967.98% year-on-year from $2.9 million in Q1 2025, and down 7.27% on a QoQ basis from $33.2 million in Q4 2025.
Jushi Holdings (JUSHF) Other Non-Current Liabilities (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Other Non-Current Liabilities data on file, last reported at $30.8 million in Q1 2026.
- On a quarterly basis, Other Non-Current Liabilities rose 967.98% year-over-year to $30.8 million in Q1 2026; TTM through Mar 2026 was $30.8 million, a 967.98% increase from a year earlier, with the FY2025 full-year figure at $33.2 million, down 14.09% from the prior year.
- Other Non-Current Liabilities for Q1 2026 stood at $30.8 million, down from $33.2 million in the prior quarter.
- Over the last five years, Other Non-Current Liabilities for JUSHF reached as high as $136.1 million in Q3 2024 and fell as low as $2.9 million in Q1 2025.
- Historically, Other Non-Current Liabilities has averaged $47.6 million across 5 years, with a median of $31.5 million in 2023.
- Across the five-year window, Other Non-Current Liabilities surged 1689.06% in 2024 and slumped 97.59% in 2025, its largest moves.
- Year by year, Other Non-Current Liabilities stood at $14.1 million in 2022, then soared by 640.24% to $104.6 million in 2023, then tumbled by 63.06% to $38.7 million in 2024, then dropped by 14.09% to $33.2 million in 2025, then decreased by 7.27% to $30.8 million in 2026.
- Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $30.8 million in Q1 2026, $33.2 million in Q4 2025, and $9.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.79 Mn |
| Dec 31, 2025 | 33.21 Mn |
| Sep 30, 2025 | 9.40 Mn |
| Jun 30, 2025 | 3.07 Mn |
| Mar 31, 2025 | 2.88 Mn |
| Dec 31, 2024 | 38.65 Mn |
| Sep 30, 2024 | 136.09 Mn |
| Jun 30, 2024 | 127.14 Mn |
| Mar 31, 2024 | 109.20 Mn |
| Dec 31, 2023 | 104.63 Mn |
| Sep 30, 2023 | 10.57 Mn |
| Jun 30, 2023 | 31.45 Mn |
| Mar 31, 2023 | 6.10 Mn |
| Dec 31, 2022 | 14.13 Mn |
| Sep 30, 2022 | 19.80 Mn |
| Jun 30, 2022 | 71.10 Mn |
| Mar 31, 2022 | 61.28 Mn |
| Dec 31, 2021 | 92.44 Mn |